VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
1-Year Return
24.65%
This Quarter Return
+7.26%
1 Year Return
+24.65%
3 Year Return
+82.72%
5 Year Return
+113.39%
10 Year Return
–
AUM
$1.85B
AUM Growth
+$639M
(+53%)
Cap. Flow
+$572M
Cap. Flow
% of AUM
30.98%
Top 10 Holdings %
Top 10 Hldgs %
16.26%
Holding
807
New
369
Increased
263
Reduced
92
Closed
81
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$18M |
| 2 |
IPG Photonics
IPGP
|
+$14M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$13.8M |
| 4 |
Cadence Design Systems
CDNS
|
+$12.8M |
| 5 |
RAVN
Raven Industries Inc
RAVN
|
+$12.5M |
Top Sells
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$3.46M |
| 2 |
Huntsman Corp
HUN
|
+$2.99M |
| 3 |
State Street
STT
|
+$2.9M |
| 4 |
Principal Financial Group
PFG
|
+$2.84M |
| 5 |
LPNT
LifePoint Health, Inc.
LPNT
|
+$2.76M |
Sector Composition
| 1 | Technology | 23.13% |
| 2 | Industrials | 13.88% |
| 3 | Healthcare | 11.61% |
| 4 | Financials | 7.62% |
| 5 | Consumer Discretionary | 7.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Incyte
INCY
$16.8B
| $1.32M | 0.07% |
9,752
+1,184
| +14% | +$160K |
|
327
Pfizer
PFE
$140B
| $1.32M | 0.07% |
38,915
+24,556
| +171% | +$832K |
|
328
PepsiCo
PEP
$196B
| $1.32M | 0.07% |
+11,796
| New | +$1.32M |
|
|
BBBY
329
DELISTED
Bed Bath & Beyond Inc
BBBY
| $1.31M | 0.07% |
55,815
+5,348
| +11% | +$126K |
|
330
Target
TGT
$41.2B
| $1.31M | 0.07% |
+22,191
| New | +$1.31M |
|
331
McDonald's
MCD
$223B
| $1.3M | 0.07% |
8,286
+6,302
| +318% | +$987K |
|
332
Alaunos Therapeutics
TCRT
$4.98M
| $1.3M | 0.07% |
1,408
+43
| +3% | +$39.6K |
|
333
Xencor
XNCR
$597M
| $1.29M | 0.07% |
56,137
+1,701
| +3% | +$39K |
|
|
TWX
334
DELISTED
Time Warner Inc
TWX
| $1.28M | 0.07% |
+12,463
| New | +$1.28M |
|
|
BLCM
335
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $1.27M | 0.07% |
10,965
+333
| +3% | +$38.4K |
|
336
Eli Lilly
LLY
$673B
| $1.26M | 0.07% |
14,712
+10,989
| +295% | +$940K |
|
337
Microsoft
MSFT
$3.71T
| $1.26M | 0.07% |
16,848
+3,390
| +25% | +$253K |
|
338
Syndax Pharmaceuticals
SNDX
$1.37B
| $1.25M | 0.07% |
106,794
+3,236
| +3% | +$37.8K |
|
|
AGN
339
DELISTED
Allergan plc
AGN
| $1.24M | 0.07% |
6,052
+4,745
| +363% | +$973K |
|
340
Novartis
NVS
$248B
| $1.24M | 0.07% |
16,079
+486
| +3% | +$37.4K |
|
341
Edwards Lifesciences
EW
$46.7B
| $1.23M | 0.07% |
+33,711
| New | +$1.23M |
|
342
AbbVie
ABBV
$370B
| $1.22M | 0.07% |
+13,694
| New | +$1.22M |
|
343
Alibaba
BABA
$347B
| $1.21M | 0.07% |
+7,024
| New | +$1.21M |
|
344
MacroGenics
MGNX
$107M
| $1.21M | 0.07% |
65,269
+1,977
| +3% | +$36.5K |
|
345
Annaly Capital Management
NLY
$14.2B
| $1.2M | 0.06% |
24,510
+21,807
| +807% | +$1.06M |
|
|
KDNY
346
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $1.17M | 0.06% |
21,963
+552
| +3% | +$29.4K |
|
347
Wynn Resorts
WYNN
$12.7B
| $1.17M | 0.06% |
+7,836
| New | +$1.17M |
|
348
AstraZeneca
AZN
$251B
| $1.15M | 0.06% |
33,983
+1,029
| +3% | +$34.9K |
|
|
GCI
349
DELISTED
Gannett Co., Inc
GCI
| $1.15M | 0.06% |
127,867
-7,375
| -5% | -$66.4K |
|
|
ALXN
350
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.13M | 0.06% |
+8,065
| New | +$1.13M |
|